Shopping Cart 0
Cart Subtotal
AED 0

Genetic Testing Market Size & Share to Boom at Double-Digit CAGR During Forecast Year 2020-2030

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option : NO
Copy Option : No
Download Option: No
Deliverable Format : Excel viewable on the website via username

Excel Only
AED 11010

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 18350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 27525

Details

Market Overview

Genetic tests are medical instruments that come in the form of kits or panels and are used to diagnose genetic illnesses in people. Furthermore, blood samples from patients are collected throughout the exam. These samples are then tested utilizing test kits on laboratory equipment. Measurement of the results of genetic alterations, such as RNA analysis as an output of gene expression, or biochemical analysis to quantify particular protein production, are examples of genetic testing. Numerous sorts of tests are utilized to diagnose genetic abnormalities. Predictive testing, carrier testing, prenatal and neonatal testing, diagnostic testing, pharmacogenomic testing, nutrigenomics, and other genetic tests are available to detect diseases. Newborn testing, for example, can detect genetic diseases early in life, allowing treatment to begin as soon as feasible. In addition, these tests are utilized to diagnose medical disorders such as cancer, hereditary disorders, and cardiovascular disease.

Genetic testing market: Key Players

  • Abbott Laboratories

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • Bio-Rad Laboratories Inc.
  • Myriad Genetics, Inc. (Myriad RBM, Inc.)
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche AG
  • Eurofins Scientific
  • Illumina Inc.
  • Thermo Fisher Scientific
  • Danaher Corporation (Cepheid Inc)
  • RainDance Technologies Inc.

 

Growth Factor

Genetic testing for Cancer cure

According to the World Health Organization, cancer led to the deaths of 9.6 million people globally in 2018. These figures are concerning since the illness is at an all-time high, impacting the whole planet and bordering on epidemic proportions. Breast cancer, ovarian cancer, bowel cancer, womb cancer, and prostate cancer can all be diagnosed quickly thanks to genetic testing. A family history of cancer is required for genetic testing and assistance in the prevention of this devastating illness. This application sector was one of the most popular in the genetic testing market, and it is predicted to continue to develop gradually in future.

 

Segmentation

  • By Types of Testing
    • Newborn Screening
    • Diagnostic Testing
    • Carrier Testing
    • Prenatal Testing
    • Forensic Testing
    • Predictive and Presymptomatic Testing
    • Others
  • By Methods
    • Molecular Genetic Testing
    • Chromosomal Genetic Testing
    • Biochemical Genetic Testing
    • Others 
  • By Testing Sample
    • Blood
    • Saliva
    • Hair
    • Tumors
    • Others 
  • By Industry
    • Laboratories 
    • Blood Banks
    • Nursing Homes
    • Hospitals 
    • Others
  • Genetic Testing Market Dynamics
  • Genetic Testing Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

 

Recent News Related to Market

  1. The FDA extended the approval of a cancer blood test called "liquid biopsy" in November 2020, which identifies genetic changes in tumor DNA in the blood and can assist match patients to prospective therapies.
  2. In August 2020, Guardant360 CDx of Guardant Health and FoundationOne Liquid CDx of Foundation Medicine were authorized by the FDA for use as a companion diagnostic test and for general tumor profiling.

 

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

  • COVID-19 pre and post business impact analysis
  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • What is the Genetic testing market growth?
  • Which segment accounted for the largest Genetic testing market share?
  • Who are the key players in the Genetic testing market?
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

 

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

READ MORE

Table Of Content

Scope

Contents          

  1. Executive Summary
  2. Global Genetic Testing Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Genetic testing market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Genetic Testing market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Genetic Testing Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Middle East and Africa: (Saudi Arabia, South Africa, UAE and rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Latin America (Brazil, Mexico and Argentina, Rest of South America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Types of Testing: Market Share (2020-2030F)
      1. Newborn Screening, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Diagnostic testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Carrier testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Prenatal testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Forensic testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      6. Predictive and presymtomatic testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      7. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Methods: Market Share (2020-2030F)
      1. Molecular Genetic Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Chromosomal Genetic Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Biochemical Genetic Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. By Testing Sample: Market Share (2020-2030F)
      1. Blood, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Saliva, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Hair, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Tumors, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    5. By Industry: Market Share (2020-2030F)
      1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Nursing homes, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Blood Banks, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile

  1. Abbott Laboratories
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. Bio-Rad Laboratories Inc.
  3. Myriad Genetics, Inc. (Myriad RBM, Inc.)
  4. Danaher Corporation (Cepheid)
  5. F. Hoffmann-La Roche AG
  6. Eurofins Scientific
  7. Illumina Inc.
  8. Thermo Fisher Scientific
  9. Danaher Corporation (Cepheid Inc)
  10. RainDance Technologies Inc.

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Licence Rights

  • Single User License:

    Access to the soft copy of the report will be granted to individual user/ Authorized User within the organization. The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete/part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. The report will be MAC address protected and will only be accessible on 1 platform.

  •  
  • Hard Copy License:

    The license provides the access to hard copy/ printed copy of the report to the Authorized User only. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. No soft copy access will be provided in this case.

  •  
  • Corporate User License:

    Access to the soft copy of the report will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Market Overview

Genetic tests are medical instruments that come in the form of kits or panels and are used to diagnose genetic illnesses in people. Furthermore, blood samples from patients are collected throughout the exam. These samples are then tested utilizing test kits on laboratory equipment. Measurement of the results of genetic alterations, such as RNA analysis as an output of gene expression, or biochemical analysis to quantify particular protein production, are examples of genetic testing. Numerous sorts of tests are utilized to diagnose genetic abnormalities. Predictive testing, carrier testing, prenatal and neonatal testing, diagnostic testing, pharmacogenomic testing, nutrigenomics, and other genetic tests are available to detect diseases. Newborn testing, for example, can detect genetic diseases early in life, allowing treatment to begin as soon as feasible. In addition, these tests are utilized to diagnose medical disorders such as cancer, hereditary disorders, and cardiovascular disease.

Genetic testing market: Key Players

  • Abbott Laboratories

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • Bio-Rad Laboratories Inc.
  • Myriad Genetics, Inc. (Myriad RBM, Inc.)
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche AG
  • Eurofins Scientific
  • Illumina Inc.
  • Thermo Fisher Scientific
  • Danaher Corporation (Cepheid Inc)
  • RainDance Technologies Inc.

 

Growth Factor

Genetic testing for Cancer cure

According to the World Health Organization, cancer led to the deaths of 9.6 million people globally in 2018. These figures are concerning since the illness is at an all-time high, impacting the whole planet and bordering on epidemic proportions. Breast cancer, ovarian cancer, bowel cancer, womb cancer, and prostate cancer can all be diagnosed quickly thanks to genetic testing. A family history of cancer is required for genetic testing and assistance in the prevention of this devastating illness. This application sector was one of the most popular in the genetic testing market, and it is predicted to continue to develop gradually in future.

 

Segmentation

  • By Types of Testing
    • Newborn Screening
    • Diagnostic Testing
    • Carrier Testing
    • Prenatal Testing
    • Forensic Testing
    • Predictive and Presymptomatic Testing
    • Others
  • By Methods
    • Molecular Genetic Testing
    • Chromosomal Genetic Testing
    • Biochemical Genetic Testing
    • Others 
  • By Testing Sample
    • Blood
    • Saliva
    • Hair
    • Tumors
    • Others 
  • By Industry
    • Laboratories 
    • Blood Banks
    • Nursing Homes
    • Hospitals 
    • Others
  • Genetic Testing Market Dynamics
  • Genetic Testing Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

 

Recent News Related to Market

  1. The FDA extended the approval of a cancer blood test called "liquid biopsy" in November 2020, which identifies genetic changes in tumor DNA in the blood and can assist match patients to prospective therapies.
  2. In August 2020, Guardant360 CDx of Guardant Health and FoundationOne Liquid CDx of Foundation Medicine were authorized by the FDA for use as a companion diagnostic test and for general tumor profiling.

 

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

  • COVID-19 pre and post business impact analysis
  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • What is the Genetic testing market growth?
  • Which segment accounted for the largest Genetic testing market share?
  • Who are the key players in the Genetic testing market?
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

 

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

READ MORE

Scope

Contents          

  1. Executive Summary
  2. Global Genetic Testing Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Genetic testing market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Genetic Testing market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Genetic Testing Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Middle East and Africa: (Saudi Arabia, South Africa, UAE and rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Latin America (Brazil, Mexico and Argentina, Rest of South America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Types of Testing: Market Share (2020-2030F)
      1. Newborn Screening, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Diagnostic testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Carrier testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Prenatal testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Forensic testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      6. Predictive and presymtomatic testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      7. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Methods: Market Share (2020-2030F)
      1. Molecular Genetic Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Chromosomal Genetic Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Biochemical Genetic Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. By Testing Sample: Market Share (2020-2030F)
      1. Blood, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Saliva, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Hair, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Tumors, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    5. By Industry: Market Share (2020-2030F)
      1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Nursing homes, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Blood Banks, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile

  1. Abbott Laboratories
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. Bio-Rad Laboratories Inc.
  3. Myriad Genetics, Inc. (Myriad RBM, Inc.)
  4. Danaher Corporation (Cepheid)
  5. F. Hoffmann-La Roche AG
  6. Eurofins Scientific
  7. Illumina Inc.
  8. Thermo Fisher Scientific
  9. Danaher Corporation (Cepheid Inc)
  10. RainDance Technologies Inc.

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

  • Single User License:

    Access to the soft copy of the report will be granted to individual user/ Authorized User within the organization. The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete/part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. The report will be MAC address protected and will only be accessible on 1 platform.

  •  
  • Hard Copy License:

    The license provides the access to hard copy/ printed copy of the report to the Authorized User only. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. No soft copy access will be provided in this case.

  •  
  • Corporate User License:

    Access to the soft copy of the report will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS